TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9262113
log Bayes Factor = 10.8669
Chromosome 6   position 30,532,278  (GRCh37) Explore rs9262113 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
E10.9 Without complications
0.000 0.296 0.704
E10 Insulin-dependent diabetes mellitus
0.000 0.326 0.674
E10.1 With ketoacidosis
0.000 0.372 0.628
E10.3 With ophthalmic complications
0.000 0.418 0.582
E10.4 With neurological complications
0.000 0.428 0.572
E10.2 With renal complications
0.000 0.462 0.537
E10.5 With peripheral circulatory complications
0.000 0.491 0.509
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.510 0.490
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.512 0.488
E10.8 With unspecified complications
0.000 0.516 0.484
E10.7 With multiple complications
0.000 0.516 0.484
E10.6 With other specified complications
0.000 0.516 0.484
E10.0 With coma
0.000 0.516 0.484
C85.1 B-cell lymphoma, unspecified
0.000 0.527 0.473
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.554 0.446
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.558 0.442
C83.3 Large cell (diffuse)
0.000 0.577 0.423
C83.0 Small cell (diffuse)
0.000 0.594 0.406
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.609 0.391
C88 Malignant immunoproliferative diseases
0.000 0.627 0.373
C83.1 Small cleaved cell (diffuse)
0.000 0.630 0.370
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.650 0.350
C85.0 Lymphosarcoma
0.000 0.650 0.350
C92 Myeloid leukaemia
0.000 0.651 0.349
C91 Lymphoid leukaemia
0.000 0.655 0.345
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.668 0.332
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.679 0.321
C93 Monocytic leukaemia
0.000 0.680 0.320
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.680 0.320
C95 Leukaemia of unspecified cell type
0.000 0.680 0.320
C94 Other leukaemias of specified cell type
0.000 0.680 0.320
C86 Other specified types of T/NK-cell lymphoma
0.000 0.680 0.320
C83.6 Undifferentiated (diffuse)
0.000 0.683 0.317
C83.5 Lymphoblastic (diffuse)
0.000 0.683 0.317
C83.4 Immunoblastic (diffuse)
0.000 0.683 0.317
C83.2 Mixed small and large cell (diffuse)
0.000 0.683 0.317
C83.7 Burkitt's tumour
0.000 0.688 0.312
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.689 0.311
C91.1 Chronic lymphocytic leukaemia
0.000 0.692 0.308
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.700 0.300
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.701 0.299
C92.0 Acute myeloid leukaemia
0.000 0.720 0.280
C92.1 Chronic myeloid leukaemia
0.000 0.731 0.269
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.732 0.268
C88.7 Other malignant immunoproliferative diseases
0.000 0.732 0.268
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.732 0.268
C88.3 Immunoproliferative small intestinal disease
0.000 0.732 0.268
C88.2 Gamma heavy chain disease
0.000 0.732 0.268
C88.1 Alpha heavy chain disease
0.000 0.732 0.268
C90.2 Plasmacytoma, extramedullary
0.000 0.739 0.261
C92.9 Myeloid leukaemia, unspecified
0.000 0.749 0.250
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.749 0.250
C92.7 Other myeloid leukaemia
0.000 0.749 0.250
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.749 0.250
C92.5 Acute myelomonocytic leukaemia
0.000 0.749 0.250
C92.3 Myeloid sarcoma
0.000 0.749 0.250
C92.2 Subacute myeloid leukaemia
0.000 0.749 0.250
C91.9 Lymphoid leukaemia, unspecified
0.000 0.750 0.250
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.752 0.248
C91.7 Other lymphoid leukaemia
0.000 0.752 0.248
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.752 0.248
C91.3 Prolymphocytic leukaemia
0.000 0.752 0.248
C91.2 Subacute lymphocytic leukaemia
0.000 0.752 0.248
C90.0 Multiple myeloma
0.000 0.760 0.240
C90.3 Solitary plasmacytoma
0.000 0.762 0.238
C91.4 Hairy-cell leukaemia
0.000 0.764 0.236
C93.1 Chronic monocytic leukaemia
0.000 0.769 0.230
C91.0 Acute lymphoblastic leukaemia
0.000 0.770 0.230
C93.9 Monocytic leukaemia, unspecified
0.000 0.770 0.230
C93.7 Other monocytic leukaemia
0.000 0.770 0.230
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.770 0.230
C93.2 Subacute monocytic leukaemia
0.000 0.770 0.230
C93.0 Acute monocytic leukaemia
0.000 0.770 0.230
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.771 0.229
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.771 0.229
C86.4 Blastic NK-cell lymphoma
0.000 0.771 0.229
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.771 0.229
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.771 0.229
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.771 0.229
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.771 0.229
C94.7 Other specified leukaemias
0.000 0.771 0.229
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.771 0.229
C94.5 Acute myelofibrosis
0.000 0.771 0.229
C94.4 Acute panmyelosis
0.000 0.771 0.229
C94.3 Mast cell leukaemia
0.000 0.771 0.229
C94.2 Acute megakaryoblastic leukaemia
0.000 0.771 0.229
C94.1 Chronic erythraemia
0.000 0.771 0.229
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.771 0.229
C95.9 Leukaemia, unspecified
0.000 0.771 0.229
C95.7 Other leukaemia of unspecified cell type
0.000 0.771 0.229
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.771 0.229
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.771 0.229
C95.0 Acute leukaemia of unspecified cell type
0.000 0.771 0.229
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.771 0.229
C96.8 Histiocytic sarcoma
0.000 0.771 0.229
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.771 0.229
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.771 0.229
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.771 0.229
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.771 0.229
C96.3 True histiocytic lymphoma
0.000 0.771 0.229
C96.2 Malignant mast cell tumour
0.000 0.771 0.229
C96.1 Malignant histiocytosis
0.000 0.771 0.229
C96.0 Letterer-Siwe disease
0.000 0.771 0.229
C92.4 Acute promyelocytic leukaemia
0.000 0.773 0.227
C84.5 Other and unspecified T-cell lymphomas
0.000 0.774 0.226
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.776 0.224
C90.1 Plasma cell leukaemia
0.000 0.780 0.220
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.784 0.215
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.784 0.215
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.784 0.215
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.784 0.215
C84.3 Lymphoepithelioid lymphoma
0.000 0.784 0.215
C84.2 T-zone lymphoma
0.000 0.784 0.215
C84.1 Sezary's diease
0.000 0.784 0.215
K90 Intestinal malabsorption
0.000 0.790 0.210
C84.0 Mycosis fungoides
0.000 0.793 0.207
C91.5 Adult T-cell leukaemia
0.000 0.800 0.200
C84.4 Peripheral T-cell lymphoma
0.000 0.808 0.192
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.832 0.168
C82.6 Cutaneous follicle centre lymphoma
0.000 0.839 0.160
C82.5 Diffuse follicle centre lymphoma
0.000 0.839 0.160
C82.4 Follicular lymphoma grade IIIb
0.000 0.839 0.160
C82.3 Follicular lymphoma grade IIIa
0.000 0.839 0.160
C81 Hodgkin's disease
0.001 0.840 0.159
C82.0 Small cleaved cell, follicular
0.000 0.841 0.158
K90.3 Pancreatic steatorrhoea
0.000 0.849 0.150
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.849 0.150
K90.1 Tropical sprue
0.000 0.849 0.150
C82.2 Large cell, follicular
0.000 0.850 0.150
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.852 0.147
E10-E14 Diabetes mellitus
0.000 0.858 0.142
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.858 0.141
K90.8 Other intestinal malabsorption
0.000 0.861 0.138
E13 Other specified diabetes mellitus
0.000 0.883 0.117
C81.7 Other Hodgkin's disease
0.001 0.885 0.114
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.001 0.885 0.114
C81.3 Lymphocytic depletion
0.001 0.885 0.114
C81.2 Mixed cellularity
0.001 0.885 0.114
C81.0 Lymphocytic predominance
0.001 0.887 0.112
E12 Malnutrition-related diabetes mellitus
0.000 0.898 0.102
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.900 0.100
E13.9 Without complications
0.000 0.901 0.099
E13.8 With unspecified complications
0.000 0.916 0.084
E13.7 With multiple complications
0.000 0.916 0.084
E13.6 With other specified complications
0.000 0.916 0.084
E13.5 With peripheral circulatory complications
0.000 0.916 0.084
E13.4 With neurological complications
0.000 0.916 0.084
E13.3 With ophthalmic complications
0.000 0.916 0.084
E13.2 With renal complications
0.000 0.916 0.084
E13.1 With ketoacidosis
0.000 0.916 0.084
E13.0 With coma
0.000 0.916 0.084
E05.9 Thyrotoxicosis, unspecified
0.000 0.917 0.083
C81.1 Nodular sclerosis
0.001 0.918 0.081
E14 Unspecified diabetes mellitus
0.000 0.924 0.076
K90.9 Intestinal malabsorption, unspecified
0.001 0.924 0.075
E12.9 Without complications
0.000 0.926 0.073
E12.8 With unspecified complications
0.000 0.926 0.073
E12.7 With multiple complications
0.000 0.926 0.073
E12.6 With other specified complications
0.000 0.926 0.073
E12.5 With peripheral circulatory complications
0.000 0.926 0.073
E12.4 With neurological complications
0.000 0.926 0.073
E12.3 With ophthalmic complications
0.000 0.926 0.073
E12.2 With renal complications
0.000 0.926 0.073
E12.1 With ketoacidosis
0.000 0.926 0.073
E12.0 With coma
0.000 0.926 0.073
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.937 0.063
E14.3 With ophthalmic complications
0.000 0.939 0.061
E14.4 With neurological complications
0.000 0.945 0.055
E14.7 With multiple complications
0.000 0.945 0.054
E14.6 With other specified complications
0.000 0.945 0.054
E14.5 With peripheral circulatory complications
0.000 0.945 0.054
E14.2 Withrenal complications
0.000 0.945 0.054
E14.0 With coma
0.000 0.945 0.054
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.946 0.054
E14.8 With unspecified complications
0.000 0.948 0.052
E14.1 With ketoacidosis
0.000 0.949 0.051
C81.9 Hodgkin's disease, unspecified
0.002 0.952 0.047
R31 Unspecified haematuria
0.048 0.952 0.000
E05.8 Other thyrotoxicosis
0.000 0.953 0.047
E05.5 Thyroid crisis or storm
0.000 0.954 0.045
E05.4 Thyrotoxicosis factitia
0.000 0.954 0.045
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.954 0.045
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.954 0.045
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.955 0.045
E00-E07 Disorders of thyroid gland
0.000 0.964 0.036
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.964 0.036
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.969 0.030
K90-K93 Other diseases of the digestive system
0.000 0.971 0.029
E16 Other disorders of pancreatic internal secretion
0.000 0.973 0.027
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.974 0.026
E00 Congenital iodine-deficiency syndrome
0.000 0.974 0.026
E40-E46 Malnutrition
0.000 0.975 0.025
E16.2 Hypoglycaemia, unspecified
0.000 0.975 0.025
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.977 0.023
E07 Other disorders of thyroid
0.000 0.977 0.023
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.022 0.978 0.000
E15 Nondiabetic hypoglycaemic coma
0.000 0.978 0.022
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.979 0.021
E14.9 Without complications
0.000 0.979 0.021
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.980 0.019
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.980 0.019
E16.4 Abnormal secretion of gastrin
0.000 0.980 0.019
E16.3 Increased secretion of glucagon
0.000 0.980 0.019
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.981 0.019
E06 Thyroiditis
0.000 0.981 0.019
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.981 0.019
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.981 0.019
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.981 0.019
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.981 0.019
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.981 0.019
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.981 0.019
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.981 0.019
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.981 0.019
E16.1 Other hypoglycaemia
0.000 0.981 0.019
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.981 0.018
E45 Retarded development following protein-energy malnutrition
0.000 0.981 0.018
E43 Unspecified severe protein-energy malnutrition
0.000 0.981 0.018
E42 Marasmic kwashiorkor
0.000 0.981 0.018
E41 Nutritional marasmus
0.000 0.981 0.018
E40 Kwashiorkor
0.000 0.981 0.018
E46 Unspecified protein-energy malnutrition
0.000 0.982 0.018
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.982 0.018
E65-E68 Obesity and other hyperalimentation
0.000 0.983 0.017
E07.8 Other specified disorders of thyroid
0.000 0.983 0.016
E07.1 Dyshormogenetic goitre
0.000 0.984 0.016
E07.0 Hypersecretion of calcitonin
0.000 0.984 0.016
E50-E64 Other nutritional deficiencies
0.000 0.984 0.016
K91.3 Postoperative intestinal obstruction
0.000 0.984 0.016
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.985 0.015
K93.1 Megacolon in Chagas' disease
0.000 0.985 0.015
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.985 0.015
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.985 0.015
K91.1 Postgastric surgery syndromes
0.000 0.985 0.015
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.014 0.986 0.000
E06.5 Other chronic thyroiditis
0.000 0.986 0.014
E06.4 Drug-induced thyroiditis
0.000 0.986 0.014
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.986 0.014
E06.1 Subacute thyroiditis
0.000 0.986 0.014
E06.0 Acute thyroiditis
0.000 0.986 0.014
E44.1 Mild protein-energy malnutrition
0.000 0.986 0.013
E44.0 Moderate protein-energy malnutrition
0.000 0.986 0.013
E65 Localised adiposity
0.000 0.987 0.013
E03 Other hypothyroidism
0.000 0.987 0.013
T36-T50 Poisoning by drugs, medicaments and biological substances
0.013 0.987 0.000
K91.5 Postcholecystectomy syndrome
0.000 0.987 0.013
E07.9 Disorder of thyroid, unspecified
0.000 0.987 0.013
E67 Other hyperalimentation
0.000 0.987 0.012
E68 Sequelae of hyperalimentation
0.000 0.987 0.012
E04 Other non-toxic goitre
0.000 0.987 0.013
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.012 0.988 0.000
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.988 0.012
E20-E35 Disorders of other endocrine glands
0.000 0.988 0.012
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.012 0.988 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.988 0.012
E63 Other nutritional deficiencies
0.000 0.988 0.012
E56 Other vitamin deficiencies
0.000 0.988 0.012
E50 Vitamin A deficiency
0.000 0.988 0.012
E60 Dietary zinc deficiency
0.000 0.988 0.012
E59 Dietary selenium deficiency
0.000 0.988 0.012
E58 Dietary calcium deficiency
0.000 0.988 0.012
E54 Ascorbic acid deficiency
0.000 0.988 0.012
E52 Niacin deficiency [pellagra]
0.000 0.988 0.012
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.012 0.988 0.000
E51 Thiamine deficiency
0.000 0.989 0.011
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.011 0.989 0.000
T42.1 Iminostilbenes
0.011 0.989 0.000
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.989 0.011
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.011 0.989 0.000
E06.9 Thyroiditis, unspecified
0.000 0.989 0.011
E27.1 Primary adrenocortical insufficiency
0.000 0.989 0.011
E53 Deficiency of other B group vitamins
0.000 0.989 0.011
E06.3 Autoimmune thyroiditis
0.000 0.989 0.011
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.000 0.989 0.011
R40.2 Coma, unspecified
0.000 0.989 0.011
T45.0 Antiallergic and antiemetic drugs
0.011 0.989 0.000
E55 Vitamin D deficiency
0.000 0.989 0.011
T46 Poisoning by agents primarily affecting the cardiovascular system
0.011 0.989 0.000
E27 Other disorders of adrenal gland
0.000 0.989 0.010
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.989 0.010
T39.4 Antirheumatics, not elsewhere classified
0.010 0.990 0.000
T39.2 Pyrazolone derivatives
0.010 0.990 0.000
E20 Hypoparathyroidism
0.000 0.990 0.010
T43.2 Other and unspecified antidepressants
0.010 0.990 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.010 0.990 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.010 0.990 0.000
M45.X9 Ankylosing spondylitis (Site unspecified)
0.010 0.990 0.000
E04.0 Non-toxic diffuse goitre
0.000 0.990 0.010
T42.0 Hydantoin derivatives
0.010 0.990 0.000
E03.5 Myxoedema coma
0.000 0.990 0.010
E03.4 Atrophy of thyroid (acquired)
0.000 0.990 0.010
E03.3 Postinfectious hypothyroidism
0.000 0.990 0.010
E03.1 Congenital hypothyroidism without goitre
0.000 0.990 0.010
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.990 0.010
T36 Poisoning by systemic antibiotics
0.010 0.990 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.010 0.990 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.010 0.990 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.010 0.990 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.010 0.990 0.000
T45.5 Anticoagulants
0.009 0.990 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.009 0.991 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.009 0.991 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.009 0.991 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.009 0.991 0.000
E67.8 Other specified hyperalimentation
0.000 0.991 0.009
E67.3 Hypervitaminosis D
0.000 0.991 0.009
E67.2 Megavitamin-B6 syndrome
0.000 0.991 0.009
E67.1 Hypercarotenaemia
0.000 0.991 0.009
E67.0 Hypervitaminosis A
0.000 0.991 0.009
E04.8 Other specified non-toxic goitre
0.000 0.991 0.009
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.009 0.991 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.009 0.991 0.000
T42.3 Barbiturates
0.009 0.991 0.000
T42.2 Succinimides and oxazolidinediones
0.009 0.991 0.000
E29 Testicular dysfunction
0.000 0.991 0.009
E20.9 Hypoparathyroidism, unspecified
0.000 0.991 0.009
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.991 0.009
E32 Diseases of thymus
0.000 0.991 0.009
E31 Polyglandular dysfunction
0.000 0.991 0.009
E30 Disorders of puberty, not elsewhere classified
0.000 0.991 0.009
E25 Adrenogenital disorders
0.000 0.991 0.009
T45.9 Primarily systemic and haematological agent, unspecified
0.009 0.991 0.000
T45.8 Other primarily systemic and haematological agents
0.009 0.991 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.009 0.991 0.000
T45.6 Fibrinolysis-affecting drugs
0.009 0.991 0.000
T45.4 Iron and its compounds
0.009 0.991 0.000
T45.3 Enzymes, not elsewhere classified
0.009 0.991 0.000
T45.2 Vitamins, not elsewhere classified
0.009 0.991 0.000
E50.9 Vitamin A deficiency, unspecified
0.000 0.991 0.009
E50.8 Other manifestations of vitamin A deficiency
0.000 0.991 0.009
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.991 0.009
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.991 0.009
E50.5 Vitamin A deficiency with night blindness
0.000 0.991 0.009
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.991 0.009
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.991 0.009
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.991 0.009
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.991 0.009
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.991 0.009
E56.9 Vitamin deficiency, unspecified
0.000 0.991 0.009
E56.8 Deficiency of other vitamins
0.000 0.991 0.009
E56.1 Deficiency of vitamin K
0.000 0.991 0.009
E56.0 Deficiency of vitamin E
0.000 0.991 0.009
E63.9 Nutritional deficiency, unspecified
0.000 0.991 0.009
E63.8 Other specified nutritional deficiencies
0.000 0.991 0.009
E63.1 Imbalance of constituents of food intake
0.000 0.991 0.009
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.991 0.009
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.991 0.009
E64.8 Sequelae of other nutritional deficiencies
0.000 0.991 0.009
E64.3 Sequelae of rickets
0.000 0.991 0.009
E64.2 Sequelae of vitamin C deficiency
0.000 0.991 0.009
E64.1 Sequelae of vitamin A deficiency
0.000 0.991 0.009
E64.0 Sequelae of protein-energy malnutrition
0.000 0.991 0.009
T43.4 Butyrophenone and thioxanthene neuroleptics
0.009 0.991 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.009 0.991 0.000
T46.1 Calcium-channel blockers
0.009 0.991 0.000
E34 Other endocrine disorders
0.000 0.991 0.009
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.009 0.991 0.000
E28 Ovarian dysfunction
0.000 0.991 0.009
E26 Hyperaldosteronism
0.000 0.991 0.008
E51.9 Thiamine deficiency, unspecified
0.000 0.992 0.008
E51.8 Other manifestations of thiamine deficiency
0.000 0.992 0.008
E51.1 Beriberi
0.000 0.992 0.008
T43.3 Phenothiazine antipsychotics and neuroleptics
0.008 0.992 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.008 0.992 0.000
T43.6 Psychostimulants with abuse potential
0.008 0.992 0.000
T43.9 Psychotropic drug, unspecified
0.008 0.992 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.008 0.992 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.008 0.992 0.000
E04.1 Non-toxic single thyroid nodule
0.000 0.992 0.008
E61 Deficiency of other nutrient elements
0.000 0.992 0.008
T46.5 Other antihypertensive drugs, not elsewhere classified
0.008 0.992 0.000
E53.1 Pyridoxine deficiency
0.000 0.992 0.008
E53.0 Riboflavin deficiency
0.000 0.992 0.008
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.008 0.992 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.992 0.008
E55.0 Rickets, active
0.000 0.992 0.008
E51.2 Wernicke's encephalopathy
0.000 0.992 0.008
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.008 0.992 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.008 0.992 0.000
T46.7 Peripheral vasodilators
0.008 0.992 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.008 0.992 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.008 0.992 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.008 0.992 0.000
E27.5 Adrenomedullary hyperfunction
0.000 0.992 0.008
E27.0 Other adrenocortical overactivity
0.000 0.992 0.008
E27.9 Disorder of adrenal gland, unspecified
0.000 0.992 0.008
N10 Acute tubulo-interstitial nephritis
0.008 0.992 0.000
E27.8 Other specified disorders of adrenal gland
0.000 0.992 0.008
I65.2 Occlusion and stenosis of carotid artery
0.000 0.992 0.008
T47.1 Other antacids and anti-gastric-secretion drugs
0.008 0.992 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.008 0.992 0.000
E24 Cushing's syndrome
0.000 0.992 0.007
E20.8 Other hypoparathyroidism
0.000 0.992 0.007
E20.1 Pseudohypoparathyroidism
0.000 0.992 0.007
E20.0 Idiopathic hypoparathyroidism
0.000 0.992 0.007
E03.8 Other specified hypothyroidism
0.000 0.992 0.007
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.993 0.007
T50.8 Diagnostic agents
0.007 0.993 0.000
T50.7 Analeptics and opioid receptor antagonists
0.007 0.993 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.007 0.993 0.000
T50.5 Appetite depressants
0.007 0.993 0.000
T50.4 Drugs affecting uric acid metabolism
0.007 0.993 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.007 0.993 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.007 0.993 0.000
T50.1 Loop [high-ceiling] diuretics
0.007 0.993 0.000
T50.0 Mineralocorticoids and their antagonists
0.007 0.993 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.007 0.993 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.007 0.993 0.000
T47.7 Emetics
0.007 0.993 0.000
T47.6 Antidiarrhoeal drugs
0.007 0.993 0.000
T47.5 Digestants
0.007 0.993 0.000
T47.4 Other laxatives
0.007 0.993 0.000
T47.3 Saline and osmotic laxatives
0.007 0.993 0.000
T47.2 Stimulant laxatives
0.007 0.993 0.000
T47.0 Histamine H(2)-receptor antagonists
0.007 0.993 0.000
T40.5 Cocaine
0.007 0.993 0.000
T39.0 Salicylates
0.007 0.993 0.000
E53.9 Vitamin B deficiency, unspecified
0.000 0.993 0.007
T36.0 Penicillins
0.007 0.993 0.000
M45 Ankylosing spondylitis
0.007 0.993 0.000
T36.9 Systemic antibiotic, unspecified
0.007 0.993 0.000
T36.8 Other systemic antibiotics
0.007 0.993 0.000
T36.7 Antifungal antibiotics, systemically used
0.007 0.993 0.000
T36.6 Rifamycins
0.007 0.993 0.000
T36.5 Aminoglycosides
0.007 0.993 0.000
T36.4 Tetracyclines
0.007 0.993 0.000
T36.3 Macrolides
0.007 0.993 0.000
T36.2 Chloramphenicol group
0.007 0.993 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.007 0.993 0.000
E27.2 Addisonian crisis
0.000 0.993 0.007
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.007 0.993 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.007 0.993 0.000
T37.5 Antiviral drugs
0.007 0.993 0.000
T37.4 Anthelminthics
0.007 0.993 0.000
T37.3 Other antiprotozoal drugs
0.007 0.993 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.007 0.993 0.000
T37.1 Antimycobacterial drugs
0.007 0.993 0.000
T37.0 Sulphonamides
0.007 0.993 0.000
T41.5 Therapeutic gases
0.007 0.993 0.000
T41.4 Anaesthetic, unspecified
0.007 0.993 0.000
T41.3 Local anaesthetics
0.007 0.993 0.000
T41.2 Other and unspecified general anaesthetics
0.007 0.993 0.000
T41.1 Intravenous anaesthetics
0.007 0.993 0.000
T41.0 Inhaled anaesthetics
0.007 0.993 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.007 0.993 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.007 0.993 0.000
T48.5 Anti-common-cold drugs
0.007 0.993 0.000
T48.4 Expectorants
0.007 0.993 0.000
T48.3 Antitussives
0.007 0.993 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.007 0.993 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.007 0.993 0.000
T48.0 Oxytocic drugs
0.007 0.993 0.000
T49.9 Topical agent, unspecified
0.007 0.993 0.000
T49.8 Other topical agents
0.007 0.993 0.000
T49.7 Dental drugs, topically applied
0.007 0.993 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.007 0.993 0.000
T49.5 Ophthalmological drugs and preparations
0.007 0.993 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.007 0.993 0.000
T49.3 Emollients, demulcents and protectants
0.007 0.993 0.000
T49.2 Local astringents and local detergents
0.007 0.993 0.000
T49.1 Antipruritics
0.007 0.993 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.007 0.993 0.000
T40.6 Other and unspecified narcotics
0.007 0.993 0.000
E28.2 Polycystic ovarian syndrome
0.000 0.993 0.007
M45.X2 Ankylosing spondylitis (Cervical region)
0.007 0.993 0.000
E34.0 Carcinoid syndrome
0.000 0.993 0.007
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.007 0.993 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.007 0.993 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.007 0.993 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.007 0.993 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.007 0.993 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.007 0.993 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.007 0.993 0.000
T44.0 Anticholinesterase agents
0.007 0.993 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.007 0.993 0.000
E29.1 Testicular hypofunction
0.000 0.993 0.007
E22 Hyperfunction of pituitary gland
0.000 0.993 0.007
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.007 0.993 0.000
E29.9 Testicular dysfunction, unspecified
0.000 0.993 0.007
E29.8 Other testicular dysfunction
0.000 0.993 0.007
E29.0 Testicular hyperfunction
0.000 0.993 0.007
E34.9 Endocrine disorder, unspecified
0.000 0.993 0.007
R30-R39 Symptoms and signs involving the urinary system
0.007 0.993 0.000
E25.9 Adrenogenital disorder, unspecified
0.000 0.993 0.006
E25.8 Other adrenogenital disorders
0.000 0.993 0.006
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.993 0.006
E30.9 Disorder of puberty, unspecified
0.000 0.993 0.006
E30.8 Other disorders of puberty
0.000 0.993 0.006
E30.1 Precocious puberty
0.000 0.993 0.006
E30.0 Delayed puberty
0.000 0.993 0.006
E31.9 Polyglandular dysfunction, unspecified
0.000 0.993 0.006
E31.8 Other polyglandular dysfunction
0.000 0.993 0.006
E31.1 Polyglandular hyperfunction
0.000 0.993 0.006
E31.0 Autoimmune polyglandular failure
0.000 0.993 0.006
E32.9 Disease of thymus, unspecified
0.000 0.993 0.006
E32.8 Other diseases of thymus
0.000 0.993 0.006
E32.1 Abscess of thymus
0.000 0.993 0.006
E32.0 Persistent hyperplasia of thymus
0.000 0.993 0.006
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.993 0.006
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.993 0.006

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.